Journals / Endokrinolojide Yönelişler / 2002 / Cilt: 11 - Sayı: 4

Can serum D-dimer level be used as an activation marker in sarcoidosis?

Sarkoidozlu hastalarda bir aktivasyon markeri olarak; Serum D-dimer düzeyi kullanılabilir mi?

Pages
166–169
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

DD status was found significantly correlated with the radiographie stage of disease, the presence of dyspnea, lower DLCO and elevated ACE level.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The coagulation and fibrinolytic systems have been impilicated in the pathogenesis of sarcoidosis.
📊
Key Findings & Data:Sarcodisosis patients (whether newly diagnosed or diagnosis is established before) seen in our Internal Medicine-Pulmonary Clinic between January 2000 and April 2002 were eligible to the study.The diagnosis was based on the histologie demonstration of nonnecrotizing granulomas.
💡
Conclusion & Impact:DD status was found significantly correlated with the radiographie stage of disease, the presence of dyspnea, lower DLCO and elevated ACE level.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

The coagulation and fibrinolytic systems have been impilicated in the pathogenesis of sarcoidosis. Enhanced expression of procoagulant activity was noted in bronchoal-veolar lavage fluid in patients with sarcoidosis. Intraalveolar activation of the coagulation cascade is thought to lead to the deposition of fibrin in the pulmonary interstisium and alveoli. Fibrin and its degradation products potentiate inflammation by modulating chemotaxis and endothelial cell injury. D dimer (DD) results from the breakdown of fibrin and can serve as a marker for fibrinolytic system activity. Additionally, circulating DD can be measured easily. DD levels have been shown to correlate with disease acitivity in lupus erythematosus and Crohn's disease. Significance of fibrinolysis in sarcoidosis and association of DD with disease activity in disorders potentially similiar to sarcoidosis suggest that DD may correlate with disease activity in sarcoidosis. Sarcodisosis patients (whether newly diagnosed or diagnosis is established before) seen in our Internal Medicine-Pulmonary Clinic between January 2000 and April 2002 were eligible to the study.The diagnosis was based on the histologie demonstration of nonnecrotizing granulomas. Presence of fungal or other mycobacterial organisms were excluded with special stains. Patients under the age of 18 years, clinical diagnosis without histologie confirmation and treatment with steroids within one year were the exclusion criterias. Patients had DD measured by D-Dimer Plus kits with turbidimetric test method. A titer of >375 mg/ml was considered a positive DD. In healthy individuals the circulating DD level measured by this method is: mean D-dimer level 125-375 mg/ml. DD was interpreted by technicians blinded to the patient's clinical data. Patients were also evaluated with history, physical examination, chest X-ray, ECG, spirometric tests and DLCO. Angiotensin converting enzyme (ACE ) levels, CRP; ESR and other labaratory parameters were also measured. DD was frequently positive among sarcoidosis patients.This implies that the coagulation system is active in these patients. DD status was found significantly correlated with the radiographie stage of disease, the presence of dyspnea, lower DLCO and elevated ACE level.

Özet

Koagulasyon ve fibrinolitik sistemin sarkoidoz patogenezisinde rol oynadığı ileri sürülmektedir. Sarkoidozlu hastaların bronkoalveolar lavaj sıvısında prokoagulant aktivitenin arttığı bildirilmiştir. Koagulasyon sisteminin intraalveolar aktivasyonunun, interstisyum ve alveollerde fibrin birikimine yol açtığı sanılmaktadır. Fibrin ve fibrin yıkım ürünleri kemotaksis ve endotel hücre hasarına neden olarak inflamasyonu artırırlar. D-Dimer (DD) fibrin yıkımı sonucu oluşur ve fibrinolitik sistem aktivitesini gösteren bir marker olarak kullanılabilir. Ayrıca, serum DD düzeyi kolaylıkla ölçülebilir. DD düzeylerinin SLE ve Kron hastalığında hastalık aktivitesiyle uyumlu olduğu gösterilmiştir. Sarkoidozda fibrinolizin önemi ve sarkoidoz benzeri hastalıklarda DD seviyesi yüksekliğinin hastalık aktivitesiyle ilişkili olması; serum DD ölçümünün sarkoidoz aktivitesini yansıtabileceğini düşündürmektedir. Ocak 2000 ile Nisan 2002 arasında İç Hastalıkları-Akciğer Birimi kliniğimizde yada polikliniğimizde izlediğimiz eski veya yeni tanı konulan sarkoidoz hastaları bu çalışma için uygun bulundu. Sarkoidoz tanısı klinik ve histolojik olarak özel boyalarla yapılan incelemelerle fungal ve miko-bakteriyel mikroorganizmaların olmadığı non-kazeifiye (diğer granulomatöz hastalıkların dışlandığı) granulomlarm gösterilmesiyle konuldu. Çalışmaya aşağıdaki hastalar alınmadı. 1.

🔖

Cite This Article

YANARDAĞ, H. (2022). Can serum D-dimer level be used as an activation marker in sarcoidosis?. Endokrinolojide Yönelişler, Cilt: 11 - Sayı: 4, 166–169. https://ajindex.com/articles/500931

References (14)

  1. Shorr AF, Hnatiuk OW. Circulating D dimer in patients with sarcoido-sis. Chest. 117:1012-1016, 2000
  2. Perez-Rodriguez E, Jimenez D, Diaz G, Flores J. D-dimer and pulmo¬nary embolism: is there a good interpretation? Arch Intern Med.24; 160:2217-2218, 2000
  3. Idell S, Gonzalez K, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JG, Griffith DE, Weiland J, Martin TR, et al. Procoagulant acti¬vity in bronchoalveolar lavage in the adult respiratory distress syndro¬me. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis. 136(6): 1466-1674,1987
  4. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarco-idosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 14:735-737,1999
  5. Anderson DR, Wells PS, Stiell I, MacLeod B, Simms M, Gray L, Robin¬son KS, Bormanis J, Mitchell M, Lewandowski B, Flowerdew G. Ma¬nagement of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing. J Emerg Med. 19:225-230, 2000
  6. Spencer H.Pathology of the lung. 3rd ed. Philadelphia.PA:WB Saun-ders. 235-240, 1977
  7. Sato N, Takahashi H, Shibata A, Fibrinogen/fibrin degradation pro¬ducts and D-dimer in clinical practice: interpretation of discrepant re-sults.AmJ Hematol. 48:168-174, 1995
  8. Gunther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Vel-covsky HG, Morr H, Grimminger F, Walmrath D, Seeger W. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar com¬partment of patients with interstitial lung disease. Thromb Haemost. 83:853-860, 2000
  9. Korte W, Riesen W.Latex-enhanced immunoturbidimetry allows D-di¬mer determination in plasma and serum samples. Clin Chem. 46(6 Ptl): 871-872,2000
  10. Fiedler P. Latex agglutination is a valid method for the measurement of D-dimer levels. Arch Intern Med. 159:2485,1999
  11. American Thoracic Society. Standardization of spirometry-1994 upda¬ te. Am J Respir Crit Care Med 152:1107-1136,1995
  12. Perez RL, Duncan A, Hunter RL, Staton GW Jr. Elevated D dimer in the lungs and blood of patients with sarcoidosis. Chest. 103:1100- 1106, 1993
  13. Hasday JD,Backwich Pr, Lynch JP,et al.Procoagulant and plasmino- gen activator activities of bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. Exp Lung Res 14:261-278, 1988
  14. Kobayashi H.Gabazza EC.Tagach O.et al.Pro